IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Nexthera Capital LP

Q3 2016 Holdings

Filed 2016-11-14 | 33 holdings | $3.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ascendis Pharma A/S(ASND)SPONSORED ADR04351P101$2.9M146,20094.8%
Spdr S&P Biotech ETFPutPUT78464A950$26.5K400,0000.9%
Pfizer Inc(PFE)COM717081103$22.2K654,0510.7%
GlaxoSmithKline PLCSPONSORED ADR37733W105$14.9K345,0000.5%
Shire PLCSPONSORED ADR82481R106$13.0K67,0000.4%
AstraZeneca PLCCallCALL046353908$8.2K250,0000.3%
Acceleron Pharma Inc(XLRN)COM00434H108$7.9K217,8170.3%
Seattle Genetics IncCOM812578102$6.0K111,5000.2%
Insmed Inc(INSM)COM PAR $.01457669307$4.7K322,0440.2%
Adamas Pharmaceuticals Inc(ADMSEUR)COM00548A106$4.6K278,7400.1%
Aquinox Pharmaceuticals IncCOM03842B101$4.5K340,0000.1%
Lannett Co IncCOM516012101$4.4K167,0000.1%
Clovis Oncology Inc(CLVSEUR)COM189464100$4.3K120,0000.1%
Immunomedics Inc(IMMU)COM452907108$4.1K1,263,2760.1%
CoLucid Pharmaceuticals IncCOM19716T101$3.8K100,0000.1%
Eiger BioPharmaceuticals Inc(CLDNEUR)COM28249U105$3.5K264,0000.1%
Zogenix IncCOM NEW98978L204$3.0K260,0000.1%
FibroGen Inc(FGENEUR)COM31572Q808$2.6K127,6800.1%
Neuroderm LtdORD SHSM74231107$2.4K131,0000.1%
Immune Design CorpCOM45252L103$2.3K305,0000.1%
Progenics Pharmaceuticals IncCOM743187106$2.2K350,0000.1%
Advaxis IncCOM NEW007624208$2.1K200,0000.1%
Trevena IncCOM89532E109$2.0K298,8490.1%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$1.9K321,6090.1%
Aerie Pharmaceuticals Inc(AERIEUR)COM00771V108$1.9K50,0000.1%
Concert Pharmaceuticals Inc(CNCEEUR)COM206022105$1.7K167,8660.1%
Axovant Sciences LtdCOMG0750W104$1.4K100,0000.0%
Foamix Pharmaceuticals LtdSHSM46135105$1.2K125,0000.0%
Ophthotech CorpCOM683745103$1.1K24,0000.0%
VistaGen Therapeutics Inc(VTGNUSD)COM NEW92840H202$575138,1320.0%
Verastem IncCOM92337C104$447336,0000.0%
Vascular Biogenics LtdCOMM96883109$17433,3320.0%
BioPharmX CorpCOM09072X101$3257,6560.0%